Merck Reverses Higher As Keytruda, Gardasil Outplay Covid Decline; Bristol Shares Dip

topped Wall Street's first-quarter forecasts Thursday while Bristol Myers Squibb (BMY) delivered a mixed performance. Merck stock swung to a gain while and BMY stock toppled. X Cancer treatments Keytruda and Opdivo helped drive growth for Merck and Bristol, respectively. Keytruda sales continued…#bristolmyerssquibb #bmy #xcancer #keytrudaandopdivo #merck #bristol #keytruda #opdivo #gardasil #bristolmyers
Source: Reuters: Health - Category: Consumer Health News Source Type: news